Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Lineage Cell Therapeutics, Inc. (LCTX) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Lineage Cell Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 876343.
Total stock buying since 2015: $18,471,462.
Total stock sales since 2015: $2,899,274.
Total stock option exercises since 2015: $1,072,958.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2026 | 0 | $0 | 0 | $0 | 37,325 | $0 |
| 2025 | 7,894,737 | $3,000,000 | 0 | $0 | 37,325 | $0 |
| 2024 | 6,942,425 | $3,675,335 | 0 | $0 | 37,325 | $0 |
| 2023 | 10,000 | $10,900 | 0 | $0 | 50,345 | $0 |
| 2022 | 983,756 | $742,607 | 0 | $0 | 30,900 | $0 |
| 2021 | 0 | $0 | 564,425 | $1,391,274 | 699,148 | $1,005,057 |
| 2020 | 0 | $0 | 0 | $0 | 61,800 | $67,901 |
| 2019 | 44,553 | $32,271 | 0 | $0 | 192,700 | $0 |
| 2018 | 1,604 | $3,769 | 0 | $0 | 104,687 | $0 |
| 2017 | 5,099,925 | $6,789,890 | 150,000 | $420,000 | 37,500 | $0 |
| 2016 | 3,032,636 | $3,618,000 | 300,000 | $705,000 | 0 | $0 |
| 2015 | 177,000 | $598,690 | 100,000 | $383,000 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2026-02 | 0 | $0 | 0 | $0 | 37,325 | $0 |
| 2025-02 | 0 | $0 | 0 | $0 | 37,325 | $0 |
| 2025-01 | 7,894,737 | $3,000,000 | 0 | $0 | 0 | $0 |
| 2024-11 | 95,000 | $55,489 | 0 | $0 | 0 | $0 |
| 2024-08 | 10,500 | $9,345 | 0 | $0 | 0 | $0 |
| 2024-05 | 10,000 | $10,500 | 0 | $0 | 0 | $0 |
| 2024-02 | 6,826,925 | $3,600,001 | 0 | $0 | 37,325 | $0 |
| 2023-12 | 10,000 | $10,900 | 0 | $0 | 0 | $0 |
| 2023-02 | 0 | $0 | 0 | $0 | 50,345 | $0 |
| 2022-06 | 0 | $0 | 0 | $0 | 15,450 | $0 |
| 2022-03 | 983,756 | $742,607 | 0 | $0 | 15,450 | $0 |
| 2021-12 | 0 | $0 | 539,283 | $1,321,808 | 526,288 | $665,486 |
| 2021-09 | 0 | $0 | 0 | $0 | 15,450 | $0 |
| 2021-06 | 0 | $0 | 19,142 | $56,086 | 135,960 | $299,112 |
| 2021-03 | 0 | $0 | 6,000 | $13,380 | 21,450 | $40,459 |
| 2020-12 | 0 | $0 | 0 | $0 | 15,450 | $27,192 |
| 2020-09 | 0 | $0 | 0 | $0 | 15,450 | $14,476 |
| 2020-06 | 0 | $0 | 0 | $0 | 15,450 | $13,441 |
| 2020-03 | 0 | $0 | 0 | $0 | 15,450 | $12,792 |
| 2019-12 | 0 | $0 | 0 | $0 | 15,450 | $0 |
| 2019-09 | 0 | $0 | 0 | $0 | 77,250 | $0 |
| 2019-08 | 44,553 | $32,271 | 0 | $0 | 0 | $0 |
| 2019-01 | 0 | $0 | 0 | $0 | 100,000 | $0 |
| 2018-12 | 0 | $0 | 0 | $0 | 50,000 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-02-11 | Samuel George A. Iii (General Counsel and Secretary) | Option Ex | 6,075 | .00 | 0 |
| 2026-02-11 | Culley Brian M (President and CEO) | Option Ex | 31,250 | .00 | 0 |
| 2025-02-11 | Samuel George A. Iii (General Counsel) | Option Ex | 6,076 | .00 | 0 |
| 2025-02-11 | Culley Brian M (President and CEO) | Option Ex | 31,249 | .00 | 0 |
| 2025-01-27 | Bradsher Neal C | Buy | 7,894,737 | .38 | 3,000,000 |
| 2024-11-26 | Howe Jill Ann (Chief Financial Officer) | Buy | 15,000 | .59 | 8,850 |
| 2024-11-22 | Mulroy Michael H. | Buy | 40,000 | .57 | 22,639 |
| 2024-11-21 | Culley Brian M (President and CEO) | Buy | 40,000 | .60 | 24,000 |
| 2024-08-16 | Howe Jill Ann (Chief Financial Officer) | Buy | 10,500 | .89 | 9,345 |
| 2024-05-24 | Culley Brian M (President and CEO) | Buy | 10,000 | 1.05 | 10,500 |
| 2024-02-11 | Samuel George A. Iii (General Counsel/Secretary) | Option Ex | 6,076 | .00 | 0 |
| 2024-02-11 | Culley Brian M (President and CEO) | Option Ex | 31,249 | .00 | 0 |
| 2024-02-08 | Bailey Don M | Buy | 96,155 | 1.04 | 100,001 |
| 2024-02-06 | Bradsher Neal C | Buy | 6,730,770 | .52 | 3,500,000 |
| 2023-12-29 | Jayasuriya Anula | Buy | 10,000 | 1.09 | 10,900 |
| 2023-02-11 | Samuel George A. Iii (General Counsel/Secretary) | Option Ex | 6,076 | .00 | 0 |
| 2023-02-11 | Hogge Gary S. (SVP,Clinical & Medical Affairs) | Option Ex | 13,020 | .00 | 0 |
| 2023-02-11 | Culley Brian M (President and CEO) | Option Ex | 31,249 | .00 | 0 |
| 2022-06-30 | Culley Brian M (President and CEO) | Option Ex | 15,450 | .00 | 0 |
| 2022-03-31 | Culley Brian M (President and CEO) | Buy | 6,400 | 1.53 | 9,792 |
| 2022-03-31 | Culley Brian M (President and CEO) | Option Ex | 15,450 | .00 | 0 |
| 2022-03-28 | Amin Dipti | Buy | 35,000 | 1.63 | 57,049 |
| 2022-03-25 | Culley Brian M (President and CEO) | Buy | 5,250 | 1.38 | 7,244 |
| 2022-03-25 | Bradsher Neal C | Buy | 470,000 | .72 | 338,870 |
| 2022-03-24 | Mulroy Michael H. | Buy | 7,000 | 1.40 | 9,800 |
| 2022-03-24 | Bradsher Neal C | Buy | 200,000 | .71 | 142,200 |
| 2022-03-23 | Bradsher Neal C | Buy | 260,106 | .68 | 177,652 |
| 2021-12-31 | Culley Brian M (President and CEO) | Option Ex | 15,450 | .00 | 0 |
| 2021-12-29 | Hogge Gary S. (SVP,Clinical & Medical Affairs) | Sale | 37,695 | 2.46 | 92,918 |
| 2021-12-29 | Hogge Gary S. (SVP,Clinical & Medical Affairs) | Option Ex | 9,250 | .69 | 6,400 |
| 2021-12-28 | Hogge Gary S. (SVP,Clinical & Medical Affairs) | Sale | 501,588 | 2.45 | 1,228,890 |
| 2021-12-28 | Hogge Gary S. (SVP,Clinical & Medical Affairs) | Option Ex | 501,588 | 1.31 | 659,086 |
| 2021-09-30 | Culley Brian M (President and CEO) | Option Ex | 15,450 | .00 | 0 |
| 2021-06-29 | Andrews Deborah J | Sale | 19,142 | 2.93 | 56,086 |
| 2021-06-29 | Andrews Deborah J | Option Ex | 24,720 | 2.20 | 54,384 |
| 2021-06-25 | Bradsher Neal C | Option Ex | 24,720 | 2.20 | 54,384 |
| 2021-06-22 | Kingsley Alfred D | Option Ex | 61,800 | 2.20 | 135,960 |
| 2021-06-18 | Mulroy Michael H. | Option Ex | 24,720 | 2.20 | 54,384 |
| 2021-03-31 | Culley Brian M (President and CEO) | Option Ex | 15,450 | 2.35 | 36,307 |
| 2021-03-30 | Hernandez Alexandra (Sr Director Finance/Controller) | Sale | 6,000 | 2.23 | 13,380 |
| 2021-03-30 | Hernandez Alexandra (Sr Director Finance/Controller) | Option Ex | 6,000 | .69 | 4,152 |
| 2020-12-31 | Culley Brian M (President and CEO) | Option Ex | 15,450 | 1.76 | 27,192 |
| 2020-09-30 | Culley Brian M (President and CEO) | Option Ex | 15,450 | .94 | 14,476 |
| 2020-06-30 | Culley Brian M (President and CEO) | Option Ex | 15,450 | .87 | 13,441 |
| 2020-03-31 | Culley Brian M (President and CEO) | Option Ex | 15,450 | .83 | 12,792 |
| 2019-12-31 | Culley Brian M (President and CEO) | Option Ex | 15,450 | .00 | 0 |
| 2019-09-30 | Culley Brian M (President and CEO) | Option Ex | 15,450 | .00 | 0 |
| 2019-09-17 | Culley Brian M (President and CEO) | Option Ex | 61,800 | .00 | 0 |
| 2019-08-15 | Bradsher Neal C | Buy | 13,146 | .48 | 6,362 |
| 2019-08-14 | Bradsher Neal C | Buy | 1,407 | .49 | 689 |
| 2019-08-13 | Leavitt Chase C. (General Counsel/Secretary) | Buy | 5,000 | 1.02 | 5,100 |
| 2019-08-13 | Roberts Brandi (CFO & SVP, Finance) | Buy | 5,000 | 1.01 | 5,050 |
| 2019-08-13 | Culley Brian M (President and CEO) | Buy | 10,000 | 1.01 | 10,100 |
| 2019-08-13 | Bradsher Neal C | Buy | 10,000 | .50 | 4,970 |
| 2019-01-01 | Culley Brian M (President and CEO) | Option Ex | 100,000 | .00 | 0 |
| 2018-12-18 | Patton Stephana Eilene (General Counsel & Secretary) | Option Ex | 27,500 | .00 | 0 |
| 2018-12-18 | Skibsted Russell (Chief Financial Officer) | Option Ex | 22,500 | .00 | 0 |
| 2018-10-04 | Patton Stephana Eilene (General Counsel & Secretary) | Option Ex | 13,750 | .00 | 0 |
| 2018-10-04 | Skibsted Russell (Chief Financial Officer) | Option Ex | 11,250 | .00 | 0 |
| 2018-09-17 | West Michael D (Co-Chief Executive Officer) | Option Ex | 10,938 | .00 | 0 |
| 2018-09-11 | Andrews Deborah J (Director) | Buy | 1,604 | 2.35 | 3,769 |
| 2018-07-10 | Mohanty Aditya P. (Co-Chief Executive Officer) | Option Ex | 4,687 | .00 | 0 |
| 2018-07-10 | West Michael D (Co-Chief Executive Officer) | Option Ex | 1,562 | .00 | 0 |
| 2018-04-10 | Mohanty Aditya P. (Co-Chief Executive Officer) | Option Ex | 4,688 | .00 | 0 |
| 2018-04-10 | West Michael D (Co-Chief Executive Officer) | Option Ex | 1,563 | .00 | 0 |
| 2018-01-10 | Mohanty Aditya P. (Co-Chief Executive Officer) | Option Ex | 4,687 | .00 | 0 |
| 2018-01-10 | West Michael D (Co-Chief Executive Officer) | Option Ex | 1,562 | .00 | 0 |
| 2017-10-13 | Bradsher Neal C | Buy | 2,692,307 | 1.30 | 3,499,999 |
| 2017-10-10 | Mohanty Aditya P. (Co-Chief Executive Officer) | Option Ex | 4,688 | .00 | 0 |
| 2017-10-10 | West Michael D (Co-Chief Executive Officer) | Option Ex | 1,563 | .00 | 0 |
| 2017-08-23 | Skibsted Russell (Chief Financial Officer) | Buy | 2,000 | 2.64 | 5,284 |
| 2017-08-22 | Broadwood Capital Inc | Buy | 10,000 | 1.30 | 12,980 |
| 2017-08-22 | West Michael D (Co-Chief Executive Officer) | Buy | 2,000 | 2.60 | 5,198 |
| 2017-08-21 | Patton Stephana Eilene (General Counsel) | Buy | 7,500 | 2.58 | 19,380 |
| 2017-08-21 | Mohanty Aditya P. (Co-Chief Executive Officer) | Buy | 7,500 | 2.50 | 18,750 |
| 2017-08-21 | Andrews Deborah J (Director) | Buy | 2,396 | 2.50 | 5,990 |
| 2017-07-31 | Bradsher Neal C | Buy | 150,000 | 1.40 | 210,000 |
| 2017-07-31 | Kingsley Alfred D (See Remarks) | Sale | 150,000 | 2.80 | 420,000 |
| 2017-07-10 | Mohanty Aditya P. (Co-Chief Executive Officer) | Option Ex | 4,687 | .00 | 0 |
| 2017-07-10 | West Michael D (Co-Chief Executive Officer) | Option Ex | 1,562 | .00 | 0 |
| 2017-06-16 | Andrews Deborah J (Director) | Buy | 2,000 | 2.95 | 5,900 |
| 2017-05-16 | Andrews Deborah J (Director) | Buy | 2,000 | 3.21 | 6,410 |
| 2017-04-10 | Mohanty Aditya P. (Co-Chief Executive Officer) | Option Ex | 18,750 | .00 | 0 |
| 2017-04-10 | West Michael D (Co-Chief Executive Officer) | Option Ex | 6,250 | .00 | 0 |
| 2017-02-15 | Bradsher Neal C | Buy | 2,222,222 | 1.35 | 2,999,999 |
| 2016-06-21 | Bradsher Neal C | Buy | 2,732,636 | 1.20 | 3,265,500 |
| 2016-01-20 | Bradsher Neal C | Buy | 300,000 | 1.18 | 352,500 |
| 2016-01-20 | Kingsley Alfred D (See Remarks) | Sale | 300,000 | 2.35 | 705,000 |
| 2015-11-06 | Russell Angus C. (Director) | Buy | 50,000 | 3.83 | 191,500 |
| 2015-11-06 | Kingsley Alfred D (See Remarks) | Sale | 100,000 | 3.83 | 383,000 |
| 2015-11-06 | Farrell Stephen C (Director) | Buy | 50,000 | 3.83 | 191,500 |
| 2015-08-26 | Andrews Deborah J (Director) | Buy | 2,000 | 2.82 | 5,640 |
| 2015-08-18 | Cartt Stephen Lahue (Director) | Buy | 17,200 | 2.90 | 49,828 |
| 2015-08-17 | Cartt Stephen Lahue (Director) | Buy | 39,400 | 2.83 | 111,462 |
| 2015-08-14 | Cartt Stephen Lahue (Director) | Buy | 18,400 | 2.65 | 48,760 |
Insider trading activities including stock purchases, stock sales, and option exercises of LCTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Lineage Cell Therapeutics, Inc. (symbol LCTX, CIK number 876343) see the Securities and Exchange Commission (SEC) website.